Retina Gallery ~ Full Sized Retina Images

Library of Free, Non-Copyrighted Retina Images and Videos

Choose your language:

Last additions - Macular Degeneration - Age Related, Myopic, Choroidal Neovascular Membranes

myopicCNVM1_861016_02132023_09.jpg
Myopic CNVM Left Eye82 views80 year old female. VA dropped to 20/125 but improved back up to 20/50 with VabysmoNov 06, 2024
myopicCNVM1_861016_02132023_08.jpg
Myopic CNVM Left Eye90 views80 year old female. VA dropped to 20/125 but improved back up to 20/50 with VabysmoNov 06, 2024
myopicCNVM1_861016_02132023_07.jpg
Myopic CNVM Left Eye91 views80 year old female. VA dropped to 20/125 but improved back up to 20/50 with VabysmoNov 06, 2024
myopicCNVM1_861016_02132023_06.jpg
Myopic CNVM Left Eye89 views80 year old female. VA dropped to 20/125 but improved back up to 20/50 with VabysmoNov 06, 2024
myopicCNVM1_861016_02132023_05.jpg
Myopic CNVM Left Eye87 views80 year old female. VA dropped to 20/125 but improved back up to 20/50 with VabysmoNov 06, 2024
myopicCNVM1_861016_02132023_01.jpg
Myopic CNVM Left Eye96 views80 year old female. VA dropped to 20/125 but improved back up to 20/50 with VabysmoNov 06, 2024
myopicCNVM1_861016_02132023_03.jpg
Myopic CNVM Left Eye107 views80 year old female. VA dropped to 20/125 but improved back up to 20/50 with VabysmoNov 06, 2024
RAP1_31916_Follow-up_Avastin2C_Lucentis2C_Eylea2C_Vabysmo41.JPG
Wet AMD - Type 1 CNVM - RAP lesion84 views92 year old man with vision loss and very high PED. Because of worry about a PED tear, patient was treated with avastin, then lucentis, then eyelea, then vabysmo (progressively stronger meds)Sep 16, 2024
RAP1_31916_Follow-up_Avastin2C_Lucentis2C_Eylea2C_Vabysmo42.JPG
Wet AMD - Type 1 CNVM - RAP lesion82 views92 year old man with vision loss and very high PED. Because of worry about a PED tear, patient was treated with avastin, then lucentis, then eyelea, then vabysmo (progressively stronger meds)Sep 16, 2024
RAP1_31916_Follow-up_Avastin2C_Lucentis2C_Eylea2C_Vabysmo40.JPG
Wet AMD - Type 1 CNVM - RAP lesion78 views92 year old man with vision loss and very high PED. Because of worry about a PED tear, patient was treated with avastin, then lucentis, then eyelea, then vabysmo (progressively stronger meds)Sep 16, 2024
RAP_31916_080323_20.jpg
Wet AMD - Type 1 CNVM - RAP lesion73 views92 year old man with vision loss and very high PED. Because of worry about a PED tear, patient was treated with avastin, then lucentis, then eyelea, then vabysmo (progressively stronger meds)Sep 16, 2024
RAP_31916_080323_18.jpg
Wet AMD - Type 1 CNVM - RAP lesion71 views92 year old man with vision loss and very high PED. Because of worry about a PED tear, patient was treated with avastin, then lucentis, then eyelea, then vabysmo (progressively stronger meds)Sep 16, 2024
RAP_31916_080323_19.jpg
Wet AMD - Type 1 CNVM - RAP lesion86 views92 year old man with vision loss and very high PED. Because of worry about a PED tear, patient was treated with avastin, then lucentis, then eyelea, then vabysmo (progressively stronger meds)Sep 16, 2024
RAP_31916_080323_17.jpg
Wet AMD - Type 1 CNVM - RAP lesion86 views92 year old man with vision loss and very high PED. Because of worry about a PED tear, patient was treated with avastin, then lucentis, then eyelea, then vabysmo (progressively stronger meds)Sep 16, 2024
RAP_31916_080323_16.jpg
Wet AMD - Type 1 CNVM - RAP lesion82 views92 year old man with vision loss and very high PED. Because of worry about a PED tear, patient was treated with avastin, then lucentis, then eyelea, then vabysmo (progressively stronger meds)Sep 16, 2024
RAP_31916_080323_15.jpg
Wet AMD - Type 1 CNVM - RAP lesion94 views92 year old man with vision loss and very high PED. Because of worry about a PED tear, patient was treated with avastin, then lucentis, then eyelea, then vabysmo (progressively stronger meds)Sep 16, 2024
RAP_31916_080323_14.jpg
Wet AMD - Type 1 CNVM - RAP lesion67 views92 year old man with vision loss and very high PED. Because of worry about a PED tear, patient was treated with avastin, then lucentis, then eyelea, then vabysmo (progressively stronger meds)Sep 16, 2024
RAP_31916_080323_13.jpg
Wet AMD - Type 1 CNVM - RAP lesion78 views92 year old man with vision loss and very high PED. Because of worry about a PED tear, patient was treated with avastin, then lucentis, then eyelea, then vabysmo (progressively stronger meds)Sep 16, 2024
RAP_31916_080323_12.jpg
Wet AMD - Type 1 CNVM - RAP lesion92 views92 year old man with vision loss and very high PED. Because of worry about a PED tear, patient was treated with avastin, then lucentis, then eyelea, then vabysmo (progressively stronger meds)Sep 16, 2024
RAP_31916_080323_11.jpg
Wet AMD - Type 1 CNVM - RAP lesion92 views92 year old man with vision loss and very high PED. Because of worry about a PED tear, patient was treated with avastin, then lucentis, then eyelea, then vabysmo (progressively stronger meds)Sep 16, 2024
RAP_31916_080323_10.jpg
Wet AMD - Type 1 CNVM - RAP lesion74 views92 year old man with vision loss and very high PED. Because of worry about a PED tear, patient was treated with avastin, then lucentis, then eyelea, then vabysmo (progressively stronger meds)Sep 16, 2024
RAP_31916_080323_02.jpg
Wet AMD - Type 1 CNVM - RAP lesion82 views92 year old man with vision loss and very high PED. Because of worry about a PED tear, patient was treated with avastin, then lucentis, then eyelea, then vabysmo (progressively stronger meds)Sep 16, 2024
RAP_31916_080323_09.jpg
Wet AMD - Type 1 CNVM - RAP lesion84 views92 year old man with vision loss and very high PED. Because of worry about a PED tear, patient was treated with avastin, then lucentis, then eyelea, then vabysmo (progressively stronger meds)Sep 16, 2024
RAP_31916_080323_08.jpg
Wet AMD - Type 1 CNVM - RAP lesion71 views92 year old man with vision loss and very high PED. Because of worry about a PED tear, patient was treated with avastin, then lucentis, then eyelea, then vabysmo (progressively stronger meds)Sep 16, 2024
RAP_31916_080323_07.jpg
Wet AMD - Type 1 CNVM - RAP lesion90 views92 year old man with vision loss and very high PED. Because of worry about a PED tear, patient was treated with avastin, then lucentis, then eyelea, then vabysmo (progressively stronger meds)Sep 16, 2024
RAP_31916_080323_06.jpg
Wet AMD - Type 1 CNVM - RAP lesion80 views92 year old man with vision loss and very high PED. Because of worry about a PED tear, patient was treated with avastin, then lucentis, then eyelea, then vabysmo (progressively stronger meds)Sep 16, 2024
RAP_31916_080323_05.jpg
Wet AMD - Type 1 CNVM - RAP lesion82 views92 year old man with vision loss and very high PED. Because of worry about a PED tear, patient was treated with avastin, then lucentis, then eyelea, then vabysmo (progressively stronger meds)Sep 16, 2024
RAP_31916_080323_04.jpg
Wet AMD - Type 1 CNVM - RAP lesion69 views92 year old man with vision loss and very high PED. Because of worry about a PED tear, patient was treated with avastin, then lucentis, then eyelea, then vabysmo (progressively stronger meds)Sep 16, 2024
RAP_31916_080323_03.jpg
Wet AMD - Type 1 CNVM - RAP lesion93 views92 year old man with vision loss and very high PED. Because of worry about a PED tear, patient was treated with avastin, then lucentis, then eyelea, then vabysmo (progressively stronger meds)Sep 16, 2024
RAP_31916_080323_02a.jpg
Wet AMD - Type 1 CNVM - RAP lesion71 views92 year old man with vision loss and very high PED. Because of worry about a PED tear, patient was treated with avastin, then lucentis, then eyelea, then vabysmo (progressively stronger meds)Sep 16, 2024
RAP_31916_080323_01.jpg
Wet AMD - Type 1 CNVM - RAP lesion83 views92 year old man with vision loss and very high PED. Because of worry about a PED tear, patient was treated with avastin, then lucentis, then eyelea, then vabysmo (progressively stronger meds)Sep 16, 2024
AMDclassicCNVM1_80416_012324_28.jpg
wet AMD with classic extrafoveal macular neovascularization in the good eye139 views89 year old man with longstanding vision loss in the left eye presented with one month of mild vision loss in the right eye. Vision was 20/32. This eye responded to vabysmo therapy.Apr 21, 2024
AMDclassicCNVM1_80416_012324_27.jpg
wet AMD with classic extrafoveal macular neovascularization in the good eye90 views89 year old man with longstanding vision loss in the left eye presented with one month of mild vision loss in the right eye. Vision was 20/32. This eye responded to vabysmo therapy.Apr 21, 2024
AMDclassicCNVM1_80416_012324_26.jpg
wet AMD with classic extrafoveal macular neovascularization in the good eye81 views89 year old man with longstanding vision loss in the left eye presented with one month of mild vision loss in the right eye. Vision was 20/32. This eye responded to vabysmo therapy.Apr 21, 2024
AMDclassicCNVM1_80416_012324_25.jpg
wet AMD with classic extrafoveal macular neovascularization in the good eye73 views89 year old man with longstanding vision loss in the left eye presented with one month of mild vision loss in the right eye. Vision was 20/32. This eye responded to vabysmo therapy.Apr 21, 2024
AMDclassicCNVM1_80416_012324_24.jpg
wet AMD with classic extrafoveal macular neovascularization in the good eye64 views89 year old man with longstanding vision loss in the left eye presented with one month of mild vision loss in the right eye. Vision was 20/32. This eye responded to vabysmo therapy.Apr 21, 2024
AMDclassicCNVM1_80416_012324_23.jpg
wet AMD with classic extrafoveal macular neovascularization in the good eye79 views89 year old man with longstanding vision loss in the left eye presented with one month of mild vision loss in the right eye. Vision was 20/32. This eye responded to vabysmo therapy.Apr 21, 2024
AMDclassicCNVM1_80416_012324_22.jpg
wet AMD with classic extrafoveal macular neovascularization in the good eye70 views89 year old man with longstanding vision loss in the left eye presented with one month of mild vision loss in the right eye. Vision was 20/32. This eye responded to vabysmo therapy.Apr 21, 2024
AMDclassicCNVM1_80416_012324_21.jpg
wet AMD with classic extrafoveal macular neovascularization in the good eye68 views89 year old man with longstanding vision loss in the left eye presented with one month of mild vision loss in the right eye. Vision was 20/32. This eye responded to vabysmo therapy.Apr 21, 2024
AMDclassicCNVM1_80416_012324_20.jpg
wet AMD with classic extrafoveal macular neovascularization in the good eye96 views89 year old man with longstanding vision loss in the left eye presented with one month of mild vision loss in the right eye. Vision was 20/32. This eye responded to vabysmo therapy.Apr 21, 2024
AMDclassicCNVM1_80416_012324_19.jpg
wet AMD with classic extrafoveal macular neovascularization in the good eye73 views89 year old man with longstanding vision loss in the left eye presented with one month of mild vision loss in the right eye. Vision was 20/32. This eye responded to vabysmo therapy.Apr 21, 2024
AMDclassicCNVM1_80416_012324_18.jpg
wet AMD with classic extrafoveal macular neovascularization in the good eye87 views89 year old man with longstanding vision loss in the left eye presented with one month of mild vision loss in the right eye. Vision was 20/32. This eye responded to vabysmo therapy.Apr 21, 2024
AMDclassicCNVM1_80416_012324_17.jpg
wet AMD with classic extrafoveal macular neovascularization in the good eye87 views89 year old man with longstanding vision loss in the left eye presented with one month of mild vision loss in the right eye. Vision was 20/32. This eye responded to vabysmo therapy.Apr 21, 2024
AMDclassicCNVM1_80416_012324_16.jpg
wet AMD with classic extrafoveal macular neovascularization in the good eye80 views89 year old man with longstanding vision loss in the left eye presented with one month of mild vision loss in the right eye. Vision was 20/32. This eye responded to vabysmo therapy.Apr 21, 2024
AMDclassicCNVM1_80416_012324_15.jpg
wet AMD with classic extrafoveal macular neovascularization in the good eye98 views89 year old man with longstanding vision loss in the left eye presented with one month of mild vision loss in the right eye. Vision was 20/32. This eye responded to vabysmo therapy.Apr 21, 2024
AMDclassicCNVM1_80416_012324_14.jpg
wet AMD with classic extrafoveal macular neovascularization in the good eye110 views89 year old man with longstanding vision loss in the left eye presented with one month of mild vision loss in the right eye. Vision was 20/32. This eye responded to vabysmo therapy.Apr 21, 2024
AMDclassicCNVM1_80416_012324_13.jpg
wet AMD with classic extrafoveal macular neovascularization in the good eye83 views89 year old man with longstanding vision loss in the left eye presented with one month of mild vision loss in the right eye. Vision was 20/32. This eye responded to vabysmo therapy.Apr 21, 2024
AMDclassicCNVM1_80416_012324_12.jpg
wet AMD with classic extrafoveal macular neovascularization in the good eye71 views89 year old man with longstanding vision loss in the left eye presented with one month of mild vision loss in the right eye. Vision was 20/32. This eye responded to vabysmo therapy.Apr 21, 2024
AMDclassicCNVM1_80416_012324_11.jpg
wet AMD with classic extrafoveal macular neovascularization in the good eye68 views89 year old man with longstanding vision loss in the left eye presented with one month of mild vision loss in the right eye. Vision was 20/32. This eye responded to vabysmo therapy.Apr 21, 2024
AMDclassicCNVM1_80416_012324_10.jpg
wet AMD with classic extrafoveal macular neovascularization in the good eye79 views89 year old man with longstanding vision loss in the left eye presented with one month of mild vision loss in the right eye. Vision was 20/32. This eye responded to vabysmo therapy.Apr 21, 2024
AMDclassicCNVM1_80416_012324_09.jpg
wet AMD with classic extrafoveal macular neovascularization in the good eye75 views89 year old man with longstanding vision loss in the left eye presented with one month of mild vision loss in the right eye. Vision was 20/32. This eye responded to vabysmo therapy.Apr 21, 2024
AMDclassicCNVM1_80416_012324_08.jpg
wet AMD with classic extrafoveal macular neovascularization in the good eye83 views89 year old man with longstanding vision loss in the left eye presented with one month of mild vision loss in the right eye. Vision was 20/32. This eye responded to vabysmo therapy.Apr 21, 2024
AMDclassicCNVM1_80416_012324_07.jpg
wet AMD with classic extrafoveal macular neovascularization in the good eye94 views89 year old man with longstanding vision loss in the left eye presented with one month of mild vision loss in the right eye. Vision was 20/32. This eye responded to vabysmo therapy.Apr 21, 2024
AMDclassicCNVM1_80416_012324_02.jpg
wet AMD with classic extrafoveal macular neovascularization in the good eye92 views89 year old man with longstanding vision loss in the left eye presented with one month of mild vision loss in the right eye. Vision was 20/32. This eye responded to vabysmo therapy.Apr 21, 2024
AMDclassicCNVM1_80416_012324_06.jpg
wet AMD with classic extrafoveal macular neovascularization in the good eye90 views89 year old man with longstanding vision loss in the left eye presented with one month of mild vision loss in the right eye. Vision was 20/32. This eye responded to vabysmo therapy.Apr 21, 2024
AMDclassicCNVM1_80416_012324_01.jpg
wet AMD with classic extrafoveal macular neovascularization in the good eye103 views89 year old man with longstanding vision loss in the left eye presented with one month of mild vision loss in the right eye. Vision was 20/32. This eye responded to vabysmo therapy.Apr 21, 2024
AMDclassicCNVM1_80416_012324_05.jpg
wet AMD with classic extrafoveal macular neovascularization in the good eye91 views89 year old man with longstanding vision loss in the left eye presented with one month of mild vision loss in the right eye. Vision was 20/32. This eye responded to vabysmo therapy.Apr 21, 2024
AMDclassicCNVM1_80416_012324_04.jpg
wet AMD with classic extrafoveal macular neovascularization in the good eye82 views89 year old man with longstanding vision loss in the left eye presented with one month of mild vision loss in the right eye. Vision was 20/32. This eye responded to vabysmo therapy.Apr 21, 2024
AMDclassicCNVM1_80416_012324_03.jpg
wet AMD with classic extrafoveal macular neovascularization in the good eye94 views89 year old man with longstanding vision loss in the left eye presented with one month of mild vision loss in the right eye. Vision was 20/32. This eye responded to vabysmo therapy.Apr 21, 2024
large-hyperref-drusen_mikat_051523_10.jpg
Large Hyper-reflective drusen in age-related macular degeneration190 views69 year old healthy woman with 20/20 vision and no visual complaintsSep 22, 2023
large-hyperref-drusen_mikat_051523_09.jpg
Large Hyper-reflective drusen in age-related macular degeneration195 views69 year old healthy woman with 20/20 vision and no visual complaintsSep 22, 2023
large-hyperref-drusen_mikat_051523_08.jpg
Large Hyper-reflective drusen in age-related macular degeneration175 views69 year old healthy woman with 20/20 vision and no visual complaintsSep 22, 2023
large-hyperref-drusen_mikat_051523_07.jpg
Large Hyper-reflective drusen in age-related macular degeneration168 views69 year old healthy woman with 20/20 vision and no visual complaintsSep 22, 2023
large-hyperref-drusen_mikat_051523_01.jpg
Large Hyper-reflective drusen in age-related macular degeneration194 views69 year old healthy woman with 20/20 vision and no visual complaintsSep 22, 2023
large-hyperref-drusen_mikat_051523_02.jpg
Large Hyper-reflective drusen in age-related macular degeneration181 views69 year old healthy woman with 20/20 vision and no visual complaintsSep 22, 2023
large-hyperref-drusen_mikat_051523_05.jpg
Large Hyper-reflective drusen in age-related macular degeneration179 views69 year old healthy woman with 20/20 vision and no visual complaintsSep 22, 2023
large-hyperref-drusen_mikat_051523_04.jpg
Large Hyper-reflective drusen in age-related macular degeneration158 views69 year old healthy woman with 20/20 vision and no visual complaintsSep 22, 2023
large-hyperref-drusen_mikat_051523_03.jpg
Large Hyper-reflective drusen in age-related macular degeneration186 views69 year old healthy woman with 20/20 vision and no visual complaintsSep 22, 2023
normal_non-exudative-CNVM-mafly_2019-2021_montage.jpg
Non exudative MNV145 viewsSep 18, 2023
vitelliform-psdrusen_saedw_083123_09.jpg
Dry Macular Degeneration with Pseudodrusen and vitelliform lesion180 views80 year old female with 20/50 vision in both eyes. Mild blurringSep 17, 2023
vitelliform-psdrusen_saedw_083123_10.jpg
Dry Macular Degeneration with Pseudodrusen and vitelliform lesion179 views80 year old female with 20/50 vision in both eyes. Mild blurringSep 17, 2023
vitelliform-psdrusen_saedw_083123_08.jpg
Dry Macular Degeneration with Pseudodrusen and vitelliform lesion162 views80 year old female with 20/50 vision in both eyes. Mild blurringSep 17, 2023
vitelliform-psdrusen_saedw_083123_07.jpg
Dry Macular Degeneration with Pseudodrusen and vitelliform lesion148 views80 year old female with 20/50 vision in both eyes. Mild blurringSep 17, 2023
vitelliform-psdrusen_saedw_083123_06.jpg
Dry Macular Degeneration with Pseudodrusen and vitelliform lesion148 views80 year old female with 20/50 vision in both eyes. Mild blurringSep 17, 2023
vitelliform-psdrusen_saedw_083123_02.jpg
Dry Macular Degeneration with Pseudodrusen and vitelliform lesion180 views80 year old female with 20/50 vision in both eyes. Mild blurringSep 17, 2023
vitelliform-psdrusen_saedw_083123_01.jpg
Dry Macular Degeneration with Pseudodrusen and vitelliform lesion182 views80 year old female with 20/50 vision in both eyes. Mild blurringSep 17, 2023
vitelliform-psdrusen_saedw_083123_04.jpg
Dry Macular Degeneration with Pseudodrusen and vitelliform lesion175 views80 year old female with 20/50 vision in both eyes. Mild blurringSep 17, 2023
vitelliform-psdrusen_saedw_083123_03.jpg
Dry Macular Degeneration with Pseudodrusen and vitelliform lesion196 views80 year old female with 20/50 vision in both eyes. Mild blurringSep 17, 2023
myopiccnvm4_somat_090123_45.JPG
Myopic (maybe PIC) choroidal neovascular membrane with recurrence after 6 years168 views31 year old female presented with 20/100 vision OS in 2017. Was treated with Lucentis x 6 and improved to 20/32. Then she was lost to follow-up. She represented 6 years later with 20/50 vision OS and a large recurrence and restarted treatment.Sep 16, 2023
myopiccnvm3_somat_090123_44.jpg
Myopic (maybe PIC) choroidal neovascular membrane with recurrence after 6 years169 views31 year old female presented with 20/100 vision OS in 2017. Was treated with Lucentis x 6 and improved to 20/32. Then she was lost to follow-up. She represented 6 years later with 20/50 vision OS and a large recurrence and restarted treatment.Sep 16, 2023
myopiccnvm3_somat_090123_42.jpg
Myopic (maybe PIC) choroidal neovascular membrane with recurrence after 6 years155 views31 year old female presented with 20/100 vision OS in 2017. Was treated with Lucentis x 6 and improved to 20/32. Then she was lost to follow-up. She represented 6 years later with 20/50 vision OS and a large recurrence and restarted treatment.Sep 16, 2023
myopiccnvm3_somat_090123_41.jpg
Myopic (maybe PIC) choroidal neovascular membrane with recurrence after 6 years152 views31 year old female presented with 20/100 vision OS in 2017. Was treated with Lucentis x 6 and improved to 20/32. Then she was lost to follow-up. She represented 6 years later with 20/50 vision OS and a large recurrence and restarted treatment.Sep 16, 2023
myopiccnvm3_somat_090123_39.jpg
Myopic (maybe PIC) choroidal neovascular membrane with recurrence after 6 years166 views31 year old female presented with 20/100 vision OS in 2017. Was treated with Lucentis x 6 and improved to 20/32. Then she was lost to follow-up. She represented 6 years later with 20/50 vision OS and a large recurrence and restarted treatment.Sep 16, 2023
myopiccnvm3_somat_090123_38.jpg
Myopic (maybe PIC) choroidal neovascular membrane with recurrence after 6 years169 views31 year old female presented with 20/100 vision OS in 2017. Was treated with Lucentis x 6 and improved to 20/32. Then she was lost to follow-up. She represented 6 years later with 20/50 vision OS and a large recurrence and restarted treatment.Sep 16, 2023
myopiccnvm3_somat_090123_37.jpg
Myopic (maybe PIC) choroidal neovascular membrane with recurrence after 6 years163 views31 year old female presented with 20/100 vision OS in 2017. Was treated with Lucentis x 6 and improved to 20/32. Then she was lost to follow-up. She represented 6 years later with 20/50 vision OS and a large recurrence and restarted treatment.Sep 16, 2023
myopiccnvm3_somat_090123_36.jpg
Myopic (maybe PIC) choroidal neovascular membrane with recurrence after 6 years159 views31 year old female presented with 20/100 vision OS in 2017. Was treated with Lucentis x 6 and improved to 20/32. Then she was lost to follow-up. She represented 6 years later with 20/50 vision OS and a large recurrence and restarted treatment.Sep 16, 2023
myopiccnvm3_somat_090123_32.jpg
Myopic (maybe PIC) choroidal neovascular membrane with recurrence after 6 years153 views31 year old female presented with 20/100 vision OS in 2017. Was treated with Lucentis x 6 and improved to 20/32. Then she was lost to follow-up. She represented 6 years later with 20/50 vision OS and a large recurrence and restarted treatment.Sep 16, 2023
myopiccnvm3_somat_090123_35.jpg
Myopic (maybe PIC) choroidal neovascular membrane with recurrence after 6 years140 views31 year old female presented with 20/100 vision OS in 2017. Was treated with Lucentis x 6 and improved to 20/32. Then she was lost to follow-up. She represented 6 years later with 20/50 vision OS and a large recurrence and restarted treatment.Sep 16, 2023
myopiccnvm3_somat_090123_34.jpg
Myopic (maybe PIC) choroidal neovascular membrane with recurrence after 6 years163 views31 year old female presented with 20/100 vision OS in 2017. Was treated with Lucentis x 6 and improved to 20/32. Then she was lost to follow-up. She represented 6 years later with 20/50 vision OS and a large recurrence and restarted treatment.Sep 16, 2023
myopiccnvm3_somat_090123_33.jpg
Myopic (maybe PIC) choroidal neovascular membrane with recurrence after 6 years158 views31 year old female presented with 20/100 vision OS in 2017. Was treated with Lucentis x 6 and improved to 20/32. Then she was lost to follow-up. She represented 6 years later with 20/50 vision OS and a large recurrence and restarted treatment.Sep 16, 2023
myopiccnvm3_somat_090123_31.jpg
Myopic (maybe PIC) choroidal neovascular membrane with recurrence after 6 years167 views31 year old female presented with 20/100 vision OS in 2017. Was treated with Lucentis x 6 and improved to 20/32. Then she was lost to follow-up. She represented 6 years later with 20/50 vision OS and a large recurrence and restarted treatment.Sep 16, 2023
myopiccnvm3_somat_090123_25.jpg
Myopic (maybe PIC) choroidal neovascular membrane with recurrence after 6 years152 views31 year old female presented with 20/100 vision OS in 2017. Was treated with Lucentis x 6 and improved to 20/32. Then she was lost to follow-up. She represented 6 years later with 20/50 vision OS and a large recurrence and restarted treatment.Sep 16, 2023
myopiccnvm3_somat_090123_26.jpg
Myopic (maybe PIC) choroidal neovascular membrane with recurrence after 6 years141 views31 year old female presented with 20/100 vision OS in 2017. Was treated with Lucentis x 6 and improved to 20/32. Then she was lost to follow-up. She represented 6 years later with 20/50 vision OS and a large recurrence and restarted treatment.Sep 16, 2023
myopiccnvm3_somat_090123_30.jpg
Myopic (maybe PIC) choroidal neovascular membrane with recurrence after 6 years127 views31 year old female presented with 20/100 vision OS in 2017. Was treated with Lucentis x 6 and improved to 20/32. Then she was lost to follow-up. She represented 6 years later with 20/50 vision OS and a large recurrence and restarted treatment.Sep 16, 2023
myopiccnvm3_somat_090123_29.jpg
Myopic (maybe PIC) choroidal neovascular membrane with recurrence after 6 years178 views31 year old female presented with 20/100 vision OS in 2017. Was treated with Lucentis x 6 and improved to 20/32. Then she was lost to follow-up. She represented 6 years later with 20/50 vision OS and a large recurrence and restarted treatment.Sep 16, 2023
myopiccnvm3_somat_090123_28.jpg
Myopic (maybe PIC) choroidal neovascular membrane with recurrence after 6 years171 views31 year old female presented with 20/100 vision OS in 2017. Was treated with Lucentis x 6 and improved to 20/32. Then she was lost to follow-up. She represented 6 years later with 20/50 vision OS and a large recurrence and restarted treatment.Sep 16, 2023
myopiccnvm3_somat_090123_27.jpg
Myopic (maybe PIC) choroidal neovascular membrane with recurrence after 6 years141 views31 year old female presented with 20/100 vision OS in 2017. Was treated with Lucentis x 6 and improved to 20/32. Then she was lost to follow-up. She represented 6 years later with 20/50 vision OS and a large recurrence and restarted treatment.Sep 16, 2023
myopiccnvm2_somat_2017-2023_23.JPG
Myopic (maybe PIC) choroidal neovascular membrane with recurrence after 6 years160 views31 year old female presented with 20/100 vision OS in 2017. Was treated with Lucentis x 6 and improved to 20/32. Then she was lost to follow-up. She represented 6 years later with 20/50 vision OS and a large recurrence and restarted treatment.Sep 16, 2023
myopiccnvm1_somat_102317_22.jpg
Myopic (maybe PIC) choroidal neovascular membrane with recurrence after 6 years173 views31 year old female presented with 20/100 vision OS in 2017. Was treated with Lucentis x 6 and improved to 20/32. Then she was lost to follow-up. She represented 6 years later with 20/50 vision OS and a large recurrence and restarted treatment.Sep 16, 2023
myopiccnvm1_somat_102317_21.jpg
Myopic (maybe PIC) choroidal neovascular membrane with recurrence after 6 years180 views31 year old female presented with 20/100 vision OS in 2017. Was treated with Lucentis x 6 and improved to 20/32. Then she was lost to follow-up. She represented 6 years later with 20/50 vision OS and a large recurrence and restarted treatment.Sep 16, 2023
2694 files on 27 page(s) 3